Stock futures gain on coronavirus vaccine progress, retail growth

Advertisement

BEGIN ARTICLE PREVIEW:

President Trump argues the U.S. will have a great economic recovery next year unless Joe Biden is elected and raises taxes. Stocks ticked higher Friday morning after investors were greeted with some hopeful news on a COVID-19 vaccine and strong retail sales.Continue Reading BelowThe Dow Jones Industrial Average gained over 160 points, or 0.57%, while the S&P 500 and the Nasdaq rose by 0.4% each. The major averages are track to snap their three-day losing streaks pushing toward a third straight weekly advance.TickerSecurityLastChangeChange %I:DJIDOW JONES AVERAGES28664.59+170.39+0.60%SP500S&P 5003499.03+15.69+0.45%I:COMPNASDAQ COMPOSITE INDEX11780.286756+66.42+0.57%Pfizer Inc. said it could apply for emergency use of its experimental COVID-19 vaccine being co-developed with BioNTech SA as soon as the third week of November – once it has received at least two months of safety data as required by the Food and Drug Administration. The company had previously said the data might be ready even sooner — in October. In other vaccine news, Gilead Sciences Inc. is disputing a World Health Organization study that found its antiviral drug remdesivir had “little or no effect on mortality” of hospitalized COVID-19 patients.TickerSecurityLastChangeChange %PFEPFIZER INC.37.07+0.52+1.42%GILDGILEAD SCIENCES INC.62.75-0.21-0.34%Looking at the economy, retail sales …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE